ILMN

Illumina, Inc.

HealthcareMedical - Diagnostics & ResearchUSUSD

$169.37

LiveJun 03, 2026

Market cap

$25.63B

52w range

81.76 – 171.80

P / E

—

EPS

—

Volume

1.57M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Illumina, Inc.’s valuation

2DB

Whole-company transactions where ILMN is acquirer or target.

Date	Role	Counterparty	Filing
Nov 24, 2020	Acquirer	Respect	SEC →
Dec 04, 2006	Acquirer	Solexa	SEC →

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.